Online first
Research paper
Published online: 2024-10-23

open access

Page views 149
Article views/downloads 95
Get Citation

Connect on Social Media

Connect on Social Media

Association between vulvar lichen sclerosus and celiac disease in woman

Maja J. Zieba-Domalik1, Kacper Nizinski1, Dominika Orszulak1, Marta Janik2, Aleksandra Fratczak3, Beata Bergler-Czop3, Rafal Stojko1, Agnieszka Drosdzol-Cop1

Abstract

Objectives: Vulvar lichen sclerosus (VLS) is a chronic inflammatory condition involving mainly the genital area with an undetermined aetiology. Recent studies show that in up to 34% of cases in adult women, VLS coexists with allergies or autoimmune diseases like celiac disease (CD), among others. However, literature data relating strictly to the co-occurrence of celiac disease and Duhring's disease (DH) in patients with VLS are very limited. Material and methods: In our study, we sought to clarify the possible relationship between vulvar lichen sclerosus in adult women and celiac disease in its cutaneous form. The aim of the study was to demonstrate the presence of celiac disease-specific antibodies in women with VLS. The control group consisted of 41 healthy women, and the study group consisted of 50 women aged 24–83 years with diagnosed vulvar lichen sclerosus who were hospitalized in the Department of Gynaecology, Obstetrics and Gynaecologic Oncology of the Bonifraters Medical Centre in Katowice. Results: There were no significant differences in blood serum levels of CD-specific antibodies between both groups. Conclusions: The study conducted did not confirm the association between vulvar lichen sclerosus and celiac disease or Duhring's disease. The main limitation of the research was the small size of the study and control groups. Further studies on a larger group of patients are needed. They could clarify the possible mechanisms behind the co-occurrence of these two conditions. Earlier diagnostic will help prevent the development of severe and irreversible complications.

Article available in PDF format

View PDF Download PDF file

References

  1. Chamli A, Souissi A. Lichen Sclerosus. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from:. https://www.ncbi.nlm.nih.gov/books/NBK538246.
  2. Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc. 1971; 57(1): 9–30.
  3. Jensen LS, Bygum A. Childhood lichen sclerosus is a rare but important diagnosis. Dan Med J. 2012; 59(5): A4424.
  4. Drosdzol-Cop A, Orszulak D. Pediatric and Adolescent Gynecology - diagnostic and therapeutic trends. Ginekol Pol. 2022; 93(12): 939–940.
  5. Nerantzoulis I, Grigoriadis T, Michala L. Genital lichen sclerosus in childhood and adolescence-a retrospective case series of 15 patients: early diagnosis is crucial to avoid long-term sequelae. Eur J Pediatr. 2017; 176(10): 1429–1432.
  6. Orszulak D, Dulska A, Niziński K, et al. Pediatric Vulvar Lichen Sclerosus-A Review of the Literature. Int J Environ Res Public Health. 2021; 18(13).
  7. De Luca DA, Papara C, Vorobyev A, et al. Lichen sclerosus: The 2023 update. Front Med (Lausanne). 2023; 10: 1106318.
  8. Nizinski K, Orszulak D, Janik M, et al. The analysis of coexistence of celiac disease and vulvar lichen sclerosus in girls. Ginekol Pol. 2022; 93(10): 793–798.
  9. Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin Summary, Number 224. Obstet Gynecol. 2020; 136(1): 222–225.
  10. Preti M, Scurry J, Marchitelli CE, et al. Vulvar intraepithelial neoplasia. Best Pract Res Clin Obstet Gynaecol. 2014; 28(7): 1051–1062.
  11. Corazza M, Schettini N, Zedde P, et al. Vulvar Lichen Sclerosus from Pathophysiology to Therapeutic Approaches: Evidence and Prospects. Biomedicines. 2021; 9(8).
  12. Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018; 178(4): 839–853.
  13. Torres A, Zaborek-Łyczba M, Łyczba J, et al. The Importance of Immunological Disorders in the Pathogenesis of Lichen Sclerosus in Pediatric Patients: A Systematic Review. Int J Mol Sci. 2022; 23(22).
  14. Cooper SM, Ali I, Baldo M, et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008; 144(11): 1432–1435.
  15. Singh P, Arora A, Strand TA, et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018; 16(6): 823–836.
  16. Catassi C, Verdu EF, Bai JC, et al. Coeliac disease. Lancet. 2022; 399(10344): 2413–2426.
  17. Nguyen CN, Kim SJ. Dermatitis Herpetiformis: An Update on Diagnosis, Disease Monitoring, and Management. Medicina (Kaunas). 2021; 57(8).
  18. Proost S, Schlumberger W, Meyer W, et al. EUROIMMUN AG. Europlus - eine Biochip-Kombinationaus Gewebeschnitten und Einzelantigenen für die indirekteImmunfluoreszenz:Endomysium/Gliadin, AMA/M2 und Parietalzellen/Intrinsic-Faktor. Poster zum Kongress für Laboratoriumsmedizin 1996 der Deutschen Gesellschaften für Laboratoriumsmedizin und für Klinische Chemie, 17. bis 20. November 1996 in Düsseldorf. J Lab Med. 1996; 20: 670.
  19. Torres A, Zaborek-Łyczba M, Łyczba J, et al. The Importance of Immunological Disorders in the Pathogenesis of Lichen Sclerosus in Pediatric Patients: A Systematic Review. Int J Mol Sci. 2022; 23(22).
  20. Sherman V, McPherson T, Baldo M, et al. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol. 2010; 24(9): 1031–1034.
  21. Howard A, Dean D, Cooper S, et al. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Australas J Dermatol. 2004; 45(1): 12–15.
  22. Gao XH, Barnardo MC, Winsey S, et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J Invest Dermatol. 2005; 125(5): 895–899.
  23. Kupfer SS, Jabri B. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am. 2012; 22(4): 639–660.
  24. García C, Araya M. [Dermatitis herpetiformis and celiac disease]. Rev Med Chil. 2021; 149(9): 1330–1338.
  25. Fasano A. Systemic autoimmune disorders in celiac disease. Curr Opin Gastroenterol. 2006; 22(6): 674–679.
  26. Swenson CW, Menees SB, Haefner HK, et al. Lower Urinary Tract and Functional Bowel Symptoms in Women With Vulvar Diseases and Controls. Female Pelvic Med Reconstr Surg. 2015; 21(4): 211–214.
  27. Söderlund JM, Hieta NK, Kurki SH, et al. Comorbidity of Urogynecological and Gastrointestinal Disorders in Female Patients With Lichen Sclerosus. J Low Genit Tract Dis. 2023; 27(2): 156–160.
  28. Halonen P, Heikinheimo O, Hadkhale K, et al. Risk Factors for Lichen Sclerosus: A Case-Control Study of 43,000 Finnish Women. J Low Genit Tract Dis. 2024; 28(2): 164–168.
  29. Jacobs L, Gilliam A, Khavari N, et al. Association between lichen sclerosus and celiac disease: a report of three pediatric cases. Pediatr Dermatol. 2014; 31(6): e128–e131.
  30. Karadag AS, Kavala M, Ozlu E, et al. The co-occurrence of lichen sclerosus et atrophicus and celiac disease. Indian Dermatol Online J. 2014; 5(Suppl 2): S106–S108.